Potential roles of self-reactive T cells in autoimmunity: lessons from cancer immunology

被引:3
作者
Andersen, Mads Hald [1 ]
机构
[1] Copenhagen Univ Hosp, Dept Hematol, CCIT, DK-2730 Herlev, Denmark
关键词
Regulatory T cells; CD8 T cells; PD-L1; IDO; Foxp3; PLASMACYTOID DENDRITIC CELLS; INDOLEAMINE 2,3-DIOXYGENASE; PROGRAMMED DEATH-1; MOUSE MODEL; IDO; RESPONSES; PATHWAY; TOLERANCE; SUPPRESSION; CONVERSION;
D O I
10.1007/s12026-014-8559-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The immune system is a complex arrangement of cells and molecules that preserve the integrity of the organism by eliminating all elements judged to be dangerous. Several regulatory mechanisms function to terminate immune responses to antigens, return the immune system to a basal state after the antigen has been cleared, and maintain unresponsiveness, or tolerance, to self-antigens. In recent years, reports have described T cell responses to several proteins involved in regulating the immune system, particularly under malignant conditions. The present review highlights specific T cells that recognize proteins involved in three, well-defined immunosuppressive mechanisms: (1) inhibitory T cell pathways (i.e., PD-L1), (2) regulatory T cells (i.e., Foxp3(+)), and (3) metabolic enzymes, like indoleamine-2,3-dioxygenase. Cytotoxic T cells can eliminate regulatory cells, thereby suppressing and/or delaying local immune suppression; conversely, regulatory CD4(+) and non-cytotoxic CD8(+) T cells enhance target-mediated immune suppression. The apparent lack of tolerance against endogenous proteins expressed by regulatory cells is intriguing, because it suggests that self-reactive T cells play a general role of fine-tuning the immune system. Thus, T cell responses may be generally used to maintain the homeostasis of the immune system. Further exploration is warranted to investigate the potential role of auto-reactive T cells under different physiological and/or pathological conditions.
引用
收藏
页码:156 / 164
页数:9
相关论文
共 74 条
[1]   Harnessing PD-L1-specific cytotoxic T cells for anti-leukemia immunotherapy to defeat mechanisms of immune escape mediated by the PD-1 pathway [J].
Ahmad, S. M. ;
Larsen, S. K. ;
Svane, I. M. ;
Andersen, M. H. .
LEUKEMIA, 2014, 28 (01) :236-238
[2]   FOXP3-specific immunity [J].
Andersen, Mads Hald .
ONCOIMMUNOLOGY, 2013, 2 (10)
[3]   CD4 responses against IDO [J].
Andersen, Mads Hald .
ONCOIMMUNOLOGY, 2012, 1 (07) :1211-1212
[4]   The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase [J].
Andersen, Mads Hald .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (08) :1289-1297
[5]   Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients [J].
Andersen, Mads Hald ;
Sorensen, Rikke Baek ;
Brimnes, Marie K. ;
Svane, Inge Marie ;
Becker, Juergen C. ;
Straten, Per Thor .
JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (08) :2245-2256
[6]   The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice [J].
Ansari, MJI ;
Salama, AD ;
Chitnis, T ;
Smith, RN ;
Yagita, H ;
Akiba, H ;
Yamazaki, T ;
Azuma, M ;
Iwai, H ;
Khoury, SJ ;
Auchincloss, H ;
Sayegh, MH .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (01) :63-69
[7]   A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type IIFN signaling following B7 ligation [J].
Baban, B ;
Hansen, AM ;
Chandler, PR ;
Manlapat, A ;
Bingaman, A ;
Kahler, DJ ;
Munn, DH ;
Mellor, AL .
INTERNATIONAL IMMUNOLOGY, 2005, 17 (07) :909-919
[8]   IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells [J].
Baban, Babak ;
Chandler, Phillip R. ;
Sharma, Madhav D. ;
Pihkala, Jeanene ;
Koni, Pandelakis A. ;
Munn, David H. ;
Mellor, Andrew L. .
JOURNAL OF IMMUNOLOGY, 2009, 183 (04) :2475-2483
[9]   Studying the immunosuppressive role of indoleamine 2,3-dioxygenase:: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo [J].
Bauer, TM ;
Jiga, LP ;
Chuang, JJ ;
Randazzo, M ;
Opelz, G ;
Terness, P .
TRANSPLANT INTERNATIONAL, 2005, 18 (01) :95-100
[10]   Human regulatory T cells: role in autoimmune disease and therapeutic opportunities [J].
Brusko, Todd M. ;
Putnam, Amy L. ;
Bluestone, Jeffrey A. .
IMMUNOLOGICAL REVIEWS, 2008, 223 :371-390